Top compounds associated with response to C17orf78


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.1 0.04
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.07 0.04
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.04
mRNA Repligen 136 CTRPv2 pan-cancer AAC 0.073 0.04
mRNA Irinotecan CCLE pan-cancer AAC -0.1 0.05
mRNA SKI-II CTRPv2 pan-cancer AAC 0.07 0.05
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.05
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.062 0.05
mRNA WP1130 CTRPv2 pan-cancer AAC 0.067 0.05
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC 0.15 0.06
Download CSV